Bio-En Holdings Corp
Bio-En Holdings Corp does not have significant operations. Previously, it focused on building, operating, and maintaining a bio-mass to energy facility on the Island of Malta. The company was formerly known as Olivia Inc. and changed its name to Bio-En Holdings Corp in August 2014. The company was incorporated in 2011 and is based in Secaucus, New Jersey.
Bio-En Holdings Corp (BENH) - Net Assets
Latest net assets as of September 2022: $-528.97K USD
Based on the latest financial reports, Bio-En Holdings Corp (BENH) has net assets worth $-528.97K USD as of September 2022.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.68K) and total liabilities ($530.65K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-528.97K |
| % of Total Assets | -31504.94% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Bio-En Holdings Corp - Net Assets Trend (2012–2021)
This chart illustrates how Bio-En Holdings Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Bio-En Holdings Corp (2012–2021)
The table below shows the annual net assets of Bio-En Holdings Corp from 2012 to 2021.
| Year | Net Assets | Change |
|---|---|---|
| 2021-12-31 | $-484.62K | -9.45% |
| 2020-12-31 | $-442.78K | -135.86% |
| 2019-12-31 | $-187.73K | -204.88% |
| 2018-12-31 | $-61.58K | +70.60% |
| 2017-12-31 | $-209.44K | +59.58% |
| 2016-12-31 | $-518.12K | -60.66% |
| 2015-12-31 | $-322.50K | -214.59% |
| 2014-12-31 | $-102.52K | -625.13% |
| 2013-12-31 | $19.52K | +3536.97% |
| 2012-12-31 | $-568.00 | -- |
Equity Component Analysis
This analysis shows how different components contribute to Bio-En Holdings Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 84446400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2021)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $7.74K | % |
| Other Components | $352.68K | % |
| Total Equity | $-484.62K | 100.00% |
Bio-En Holdings Corp Competitors by Market Cap
The table below lists competitors of Bio-En Holdings Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
PORTMAN RIDGE FIN. DL-01
F:KJ7A
|
$68.29K |
|
J4 Ventures Inc.
V:JJJJ-P
|
$68.30K |
|
SBDS
NYSE:SBDS
|
$68.44K |
|
SODITECH
PA:ALSEC
|
$68.45K |
|
MTI Ltd
MU:MBO
|
$68.18K |
|
GRAMMER (GMM.SG)
STU:GMM
|
$68.12K |
|
NHYEX
NASDAQ:NHYEX
|
$68.11K |
|
EMAE4F
SA:EMAE4F
|
$67.98K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Bio-En Holdings Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2020 to 2021, total equity changed from -442,778 to -484,616, a change of -41,838.
- Net loss of 10,388 reduced equity.
- Other factors decreased equity by 31,450.
Equity Change Factors (2020 to 2021)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-10.39K | -2.14% |
| Other Changes | $-31.45K | -6.49% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Bio-En Holdings Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | $0.00 | $0.00 | x |
| 2013-12-31 | $0.00 | $0.00 | x |
| 2014-12-31 | $0.00 | $0.00 | x |
| 2015-12-31 | $-0.01 | $0.00 | x |
| 2016-12-31 | $-0.02 | $0.00 | x |
| 2017-12-31 | $-0.01 | $0.00 | x |
| 2018-12-31 | $0.00 | $0.00 | x |
| 2019-12-31 | $0.00 | $0.00 | x |
| 2020-12-31 | $-0.01 | $0.00 | x |
| 2021-12-31 | $-0.01 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Bio-En Holdings Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-19.42%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $-511.20 |
| 2013 | -194.19% | 0.00% | 0.00x | 1.70x | $-39.86K |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-216.75K |
| 2015 | 0.00% | -113402.06% | 0.00x | 0.00x | $-187.75K |
| 2016 | 0.00% | -116666.67% | 0.00x | 0.00x | $-144.19K |
| 2017 | 0.00% | 183739.88% | 2.80x | 0.00x | $329.63K |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-82.23K |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-107.38K |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-401.15K |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $38.07K |
Industry Comparison
This section compares Bio-En Holdings Corp's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $36,677,338
- Average return on equity (ROE) among peers: -64.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Bio-En Holdings Corp (BENH) | $-528.97K | 0.00% | N/A | $68.22K |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $931.34 Million | 0.00% | 0.08x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $3.80 Million | -5.26% | 0.34x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $8.75K | -623.31% | 2.50x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-501.57K | 0.00% | 0.00x | $13.62K |
| ACRO Biomedical Co Ltd (ACBM) | $685.87K | -17.12% | 0.46x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-19.47K | 0.00% | 0.00x | $3.15K |